Full history for every metric is available with a Kvantra account
Elos Medtech AB (publ) (ELOS-B.ST)
Key financial summary
Financials in SEK| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | TTM | ||
|---|---|---|---|---|---|---|---|---|
| Total revenue | SEK m | 578 | 645 | 689 | 580 | 724 | 889 | 1,018 |
| Operating profit | SEK m | 122 | 123 | |||||
| Net profit | SEK m | 23 | 21 | 39 | 36 | 76 | 75 | 55 |
| EPS reported | SEK | 9.30 | 6.82 | |||||
| Operating cashflow per share | SEK | 13.42 | 13.42 | |||||
| Capex per share | SEK | 14.53 | 14.53 | |||||
| FCF per share | SEK | -1.11 | -1.11 | |||||
| Free cash flow | SEK m | -9 | -52 | |||||
| Net debt | SEK m | -169 | -117 | |||||
| Book value equity | SEK m | 798 | 788 | |||||
| Book value per share | SEK | 98.97 | 97.80 | |||||
| Number of shares | m | 8.07 | 8.06 | |||||
| DPS (TTM paid) | SEK | 0.00 | 0.00 |
Financial summary
Financials in SEK| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | TTM | ||
|---|---|---|---|---|---|---|---|---|
| Value | ||||||||
| P/E TTM | x | 26.45 | - | |||||
| P/B LTM | x | 2.49 | 2.08 | |||||
| P/S LTM | x | 2.23 | 1.61 | |||||
| P/FCF LTM | x | -221.68 | -31.46 | |||||
| EV/EBITDA LTM | x | 10.20 | 7.74 | |||||
| EV/Sales LTM | x | 2.04 | 1.49 | |||||
| Earnings Yield LTM | % | 3.78% | 4.58% | |||||
| FCF Yield | % | -0.45% | -3.18% | |||||
| Quality | ||||||||
| ROE | % | 9.40% | 10.48% | |||||
| ROIC | % | 7.35% | 7.35% | |||||
| Operating margin | % | 13.70% | 13.70% | |||||
| Gross margin | % | 34.94% | 34.94% | |||||
| FCF/Sales | % | -1.01% | -1.01% | |||||
| Growth and momentum | ||||||||
| EPS Growth YoY | % | -0.75% | -41.56% | |||||
| Sales Growth YoY | % | +22.80% | +20.68% | |||||
| Net Income Growth YoY | % | -0.71% | -41.66% | |||||
| FCF Growth | % | - | - | |||||
| Operating Profit Growth | % | +20.46% | -5.17% | |||||
| Dividend and capital structure | ||||||||
| Dividend Yield | % | 0.00% | 0.00% | |||||
| Dividend Growth | % | 0.00% | 0.00% | |||||
| Payout Ratio | % | 0.00% | 15.38% | |||||
| FCF/Debt | x | - | - | |||||
| Net Debt/EBITDA | x | -0.95 | -0.95 | |||||
| EBIT/Net interest | x | 0.00 | 0.00 | |||||
| Net debt/market cap | % | -8.50% | -7.16% | |||||
| Net debt/Equity | x | -0.21 | -0.15 | |||||
| Gross debt/equity | x | 0.00 | 0.00 | |||||
Company overview
Elos Medtech AB (publ) specializes in the creation and outsourced production of medical devices and their constituent components. Their expertise caters to a broad spectrum of medical sectors, including dental, orthopedic, diagnostic, and audiology fields, as well as other general medical device markets. The company's diverse product portfolio encompasses items such as implants, surgical screws, plates, specialized orthopedic and dental tools, drills, pins, wires, dental prosthetics, disposable plastic goods, HPLC fittings, and a variety of other medical plastic parts. Beyond manufacturing, Elos Medtech provides a comprehensive array of services, including product design and development, regulatory guidance, prototyping, rigorous testing, original equipment manufacturing (OEM) support, process validation, and sophisticated supply chain and inventory management, alongside design for manufacturing and general engineering services. Founded in 1923, the company has a significant global presence, with operations in Sweden, Denmark, China, and the United States. It underwent a name change from Elos AB (publ) to its current designation, Elos Medtech AB (publ), in April 2015, and is headquartered in Gothenburg, Sweden.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
Elos Medtech AB (publ) (ELOS-B.ST)
Elos Medtech AB (publ) specializes in the creation and outsourced production of medical devices and their constituent components. Their expertise caters to a broad spectrum of medical sectors, including dental, orthopedic, diagnostic, and audiology fields, as well as other general medical device markets. The company's diverse product portfolio encompasses items such as implants, surgical screws, plates, specialized orthopedic and dental tools, drills, pins, wires, dental prosthetics, disposable plastic goods, HPLC fittings, and a variety of other medical plastic parts. Beyond manufacturing, Elos Medtech provides a comprehensive array of services, including product design and development, regulatory guidance, prototyping, rigorous testing, original equipment manufacturing (OEM) support, process validation, and sophisticated supply chain and inventory management, alongside design for manufacturing and general engineering services. Founded in 1923, the company has a significant global presence, with operations in Sweden, Denmark, China, and the United States. It underwent a name change from Elos AB (publ) to its current designation, Elos Medtech AB (publ), in April 2015, and is headquartered in Gothenburg, Sweden.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free